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Table 2. Logistic regression to assess the predictive value of 25(OH)D for prevalent and incident (pre)frailty.  
Figure 1. Vitamin D status according to frailty status in 
1997 and 2000. 
Table 1. Characteristics of the study population in 1997 and 2000. 
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To assess the association: 
1) between 25-hydroxy vitamin D [25(OH)D] 
and prevalent frailty status. 
2) between 25(OH)D and incident frailty status.  
 This study is part of an observational longitudinal population-based study in 352 
ambulatory older men, that started in 1996 with yearly assessments till 2000 and 
follow-up by phone still on going.  
 Frailty status was assessed in 1997 and 2000 using the Study of Osteoporotic 
Fractures [SOF] index with the components of weight loss, inability to rise from a 
chair 5 times without using arms, and reduced energy level. 
 Blood samples were collected between July and October in 1997. Serum 25(OH)D 
was determined after extraction by radioimmunoassay. 
 Patients taking vitamin D supplements in 1997 and/or 2000 were excluded. 
Serum 25(OH)D is associated with  prevalent (pre)frailty in older men, but not with incident (pre)frailty. 
AIMS 
CONCLUSIONS 
RESULTS 
METHODS 
Continuous variables are presented as mean ± standard deviation and countable variables 
as absolute number (percentage of the total). 
Model a included age and BMI in 1997 as covariates.  
Model b included age, BMI and frailty status in 1997 as covariates. 
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P = 0.622 
P = 0.002 
246 subjects in 1997 167 subjects in 1997 and 2000 
1997 1997 2000 
Age, years 76.1 ± 3.9 75.3 ± 3.4 78.3 ± 3.4 
BMI, kg/m² 26.5 ± 3.4 26.8 ± 3.4 26.7 ± 3.5 
25(OH)D, ng/ml 26.1 ± 7.8 27.2 ± 7.6 
Vitamin D status 
Deficient (< 20 ng/ml)   47 (19%)   24 (14%) 
Insufficient (20-30 ng/ml) 120 (49%)   78 (47%) 
Sufficient (≥ 30 ng/ml)   79 (32%)   65 (39%) 
SOF frailty items 
Weight loss   16 (  7%)   11 (  7%)   18 (11%) 
Inability chair rising   18 (  7%)     7 (  4%)   11 (  7%) 
Reduced energy level   49 (20%)   21 (13%)   33 (20%) 
SOF frailty status 
Robust 175 (71%) 132 (79%) 114 (68%) 
Prefrail   61 (25%)   31 (19%)   45 (27%) 
Frail    10 (  4%)     4 (  2%)     8 (  5%) 
(pre)frailty 1997 (pre)frailty 2000 
Unadjusted model   Model a Unadjusted model   Model b 
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P 
25(OH)D, per 10 ng/ml increase 0.54 (0.37 - 0.78) 0.001 0.59 (0.40 - 0.87) 0.008 0.89 (0.58 - 1.38) 0.610 1.02 (0.64 - 1.63) 0.943 
Vitamin D Deficient vs Sufficient 4.07 (1.75 - 9.48) 0.001 3.36 (1.40 - 8.03) 0.007 1.15 (0.43 - 3.03) 0.785 0.89 (0.31 - 2.57) 0.834 
Vitaming D Insufficient vs Sufficient 2.58 (1.25 - 5.33) 0.010 2.46 (1.17 - 5.18) 0.018 0.75 (0.37 - 1.53) 0.429 0.58 (0.27 - 1.24) 0.16 
